ConnectQuest v. Oura Health: Proximity Patent Dispute Settled in Wearable Tech
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | ConnectQuest, LLC v. Oura Health Oy |
| Case Number | 6:23-cv-00421 (Fed. Cir.) |
| Court | U.S. District Court for the Western District of Texas |
| Duration | June 6, 2023 – April 30, 2024 329 days |
| Outcome | Settled / Dismissed with prejudice |
| Patents at Issue | |
| Accused Products | Oura Health’s Beacon for close proximity notification system & associated close proximity notification system |
Case Overview
The Parties
⚖️ Plaintiff
A non-practicing entity (NPE) holding a portfolio of patents directed to close proximity notification systems.
🛡️ Defendant
A Finnish corporation best known for the Oura Ring, a smart ring that monitors biometrics including heart rate, sleep, and activity.
Patents at Issue
This dispute centered on four U.S. patents covering close proximity notification systems — technology increasingly embedded in consumer wearables, health monitors, and contact-tracing platforms. These patents collectively describe systems and methods enabling devices to detect nearby entities and trigger notifications.
- • US8831642B2 — Close proximity notification and beacon technology
- • US9219979B2 — Close proximity notification and beacon technology
- • US9674688B2 — Close proximity notification and beacon technology
- • US9998906B2 — Close proximity notification and beacon technology
Developing a product with proximity sensing?
Check if your wearable tech design might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The court granted the Joint Motion to Dismiss with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(2). All claims asserted by ConnectQuest against Oura Health were dismissed. Each party bears its own attorneys’ fees, costs of court, and expenses — a standard stipulation in negotiated resolutions.
No damages amount was publicly disclosed, and no injunctive relief was ordered or denied on the merits. The confidential nature of the resolution is consistent with typical NPE settlement practice.
Key Legal Issues
The underlying cause of action was patent infringement. While the court issued no merits ruling, several strategic dynamics likely shaped the resolution: claim construction risk (with four asserted patents), validity exposure (potential for IPR petitions), and Oura Health’s commercial sensitivity to resolving IP uncertainty ahead of product expansion.
The dismissal with prejudice forecloses ConnectQuest from re-asserting these specific claims against Oura Health—a meaningful concession typically exchanged for licensing consideration. The lack of a merits ruling means the case creates no binding precedent on claim construction, validity, or infringement standards for proximity notification patents.
Freedom to Operate (FTO) Analysis in Wearable Tech
This case highlights critical IP risks in proximity-sensing wearable technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View patents in the proximity notification technology space
- Analyze competitive activity in wearable tech IP
- Understand assertion trends by NPEs
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
Active Risk Area
Bluetooth Low Energy (BLE) & NFC proximity detection
Multi-Patent Assertions
Common strategy for NPEs in this space
Proactive Diligence
Essential for new product launches
✅ Key Takeaways
Dismissal with prejudice under Rule 41(a)(2) with mutual cost-bearing strongly implies a negotiated license or settlement.
Search related case law →The Western District of Texas remains a strategically viable venue for patent plaintiffs despite evolving transfer jurisprudence.
Explore precedents →Multi-patent continuation families amplify assertion leverage but also compound claim construction and IPR risk exposure.
Analyze IPR trends →Frequently Asked Questions
Four U.S. patents were asserted: US8831642B2, US9219979B2, US9674688B2, and US9998906B2, all directed to close proximity notification and beacon systems.
The parties filed a Joint Motion to Dismiss under Fed. R. Civ. P. 41(a)(2), representing they had resolved their claims. The court granted dismissal with prejudice, with each party bearing its own costs.
While no binding precedent was established, the case signals continued NPE assertion activity targeting wearable and beacon technologies, reinforcing the need for proactive FTO analysis in this space.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER — Case No. 6:23-cv-00421
- USPTO Patent Full-Text Database (US8831642B2, US9219979B2, US9674688B2, US9998906B2)
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.